Pharmacists to offer self-injectable contraceptives in a major access boost

Guests and partners in the launch of private sector Depo Medroxy Progesterone Subcutaneous( DMPA- SC) contraceptive which is self-injected. [ Jenipher Wachie, Standard]

Pharmacies will now serve as the new frontline for contraceptive access following a new initiative aimed at expanding services to the private sector.

The launch of the Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SA) Sayana Press, to be supplied by pharmacists, offers new hope for women by reducing access barriers and reliance on healthcare facilities.